Longevity and Anti-senescence Therapy Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Longevity and Anti-senescence Therapy Market is expected to grow at a compound annual growth rate (CAGR) of 14% during 2022-2028.

Aging epigenetics refers to changes in gene expression that occur naturally during an organism’s lifetime without changes in its DNA sequence. Several enzymes are involved in chromatin epigenetics, resulting in alterations in DNA methylation and histone methylation/acetylation processes. Chromatin appears to be more active during aging, resulting in more relaxed global gene expression with an overall decrease in DNA methylation.

Market Segments

By Therapy

• Senolytic Drug Therapy
• Gene Therapy
• Immunotherapy
• Others

By Application

• Longevity
• Senescence Inhibition
• Cardiovascular Diseases
• Neural Degenerative Diseases
• Ophthalmology Disorders
• Cancer

Key Players

• Acorda Therapeutics
• Calico Life Sciences
• Human Longevity Inc.
• Insilico Medicine
• Oisin Biotechnology
• Proteostasis Therapeutics Inc.
• Recursion Pharmaceuticals
• Senex Biotechnology
• Senolytic Therapeutics
• Sierra Sciences LLC

Scope of the Report

The research study analyzes the global Longevity and Anti-senescence Therapy industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Longevity and Anti-senescence Therapy Market Report

1. What was the Longevity and Anti-senescence Therapy Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Longevity and Anti-senescence Therapy Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Longevity and Anti-senescence Therapy Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.